Improvement in the outcome of children with germ cell tumors
Authors:
- Luiz Fernando LopesLLLuiz Fernando Lopes
- Karina C.B. RibeiroKRKarina C.B. Ribeiro
- Beatriz de CamargoBCBeatriz de Camargo
- 6 June 2007
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 50 (2) , 250-253
Abstract
Purpose: To describe the clinical characteristics and estimate the survival of children and adolescents with germ cell tumors treated with cisplatin‐based combination chemotherapy according to three different protocols in Brazil.Methods: From 1983 to 1997, 106 patients were treated at the Hospital do Cancer, Sao Paulo for a diagnosis of germ cell tumor. We performed a retrospective review of the clinical and histopathological data to identify prognostic factors and evaluate their outcome.Results: Patients were treated with only surgery (n = 32), surgery and radiotherapy (n = 1) and chemotherapy (n = 73). From 1983 to 1986 (period I), there were 30 patients and 21 received chemotherapy according to the modified VAB‐6 protocol. Twenty‐two of 35 patients registered between 1987 and 1991 (period II) were treated with EPO/VAC combination chemotherapy. From 1991 to 1997 (period III), there were 41 patients and 31 received chemotherapy according to the Brazilian TCG‐91 protocol. Important prognostic factors included stage (P < 0.001), metastatic status (P < 0.001) and surgical procedure at diagnosis (P < 0.001). An incremental improvement in outcomes was noted across the periods of treatment (P = 0.070). Five‐year OS was respectively 42.9 ± 10.8%, 53.9 ± 11.4% and 80.6 ± 7.1% for periods I, II, and III for the patients who received chemotherapy.Conclusion: An improvement in the survival of children with germ cell tumors was achieved in the most recent trial (TCG‐91) with a risk adapted approach incorporating only cisplatin and etoposide. These results indicate that in selected patients complex three‐agent regimens may not be necessary to achieve long term survival. Pediatr Blood Cancer 2008;50:250–253.Keywords
This publication has 15 references indexed in Scilit:
- Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapyCancer, 2006
- Endodermal sinus tumor of the vagina in childrenMedical and Pediatric Oncology, 1999
- Malignant germ cell tumours in childhoodEuropean Journal of Cancer, 1997
- Are 3 Cycles of Bleomycin, Etoposide and Cisplatin or 4 Cycles of Etoposide and Cisplatin Equivalent Optimal Regimens for Patients with Good Risk Metastatic Germ Cell Tumors of the Testis? The Need for A Randomized TrialJournal of Urology, 1997
- Cisplatin-Based Chemotherapy in the Management of Germ Cell Tumors of the Ovary: The Institut Gustave Roussy ExperienceGynecologic Oncology, 1997
- Diagnosis and management of malignant germ cell ovarian tumors in young femalesInternational Journal of Gynecology & Obstetrics, 1996
- Endodermal sinus tumor in childrenJournal of Pediatric Surgery, 1996
- Response to high‐dose cisplatin and etoposide in advanced germ cell tumors in children: Results of the Brazilian germ cell tumor studyMedical and Pediatric Oncology, 1995
- Germ cell tumors1993
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958